Nxera Pharma Co., Ltd. (TYO: 4565)

Nxera Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	92,958	127,103	175,151	155,210	145,054	167,282
Market Cap Growth	-9.84%	-27.43%	12.85%	7.00%	-13.29%	174.39%
Enterprise Value	113,499	158,025	143,645	134,496	123,808	152,936
Last Close Price	1034.00	1421.00	2138.00	1904.00	1800.00	2171.00
PE Ratio	-	-	458.51	152.62	98.08	116.82
Forward PE	48.10	62.51	62.98	37.67	87.15	50.84
PS Ratio	3.11	9.96	11.25	8.76	16.41	17.20
PB Ratio	1.37	1.90	3.02	2.70	2.77	3.71
P/TBV Ratio	-	-	5.14	4.67	5.49	9.45
P/FCF Ratio	53.36	-	18.10	22.49	31.67	52.77
P/OCF Ratio	45.67	-	17.60	21.88	31.05	48.61
EV/Sales Ratio	3.88	12.38	9.23	7.59	14.00	15.72
EV/EBITDA Ratio	42.70	-	34.56	16.43	56.17	62.45
EV/EBIT Ratio	-	-	51.08	19.46	144.97	159.31
EV/FCF Ratio	65.15	-	14.85	19.49	27.03	48.24
Debt / Equity Ratio	1.02	1.11	0.51	0.51	0.32	0.04
Debt / EBITDA Ratio	26.11	-	7.15	3.57	7.54	0.77
Debt / FCF Ratio	39.84	-	3.07	4.24	3.63	0.59
Asset Turnover	0.19	0.10	0.16	0.20	0.13	0.17
Quick Ratio	3.73	3.55	16.90	8.67	13.96	8.28
Current Ratio	4.01	3.79	17.09	8.73	14.08	8.49
Return on Equity (ROE)	-5.90%	-11.53%	0.66%	1.85%	3.04%	3.30%
Return on Assets (ROA)	-0.54%	-5.07%	1.79%	4.98%	0.80%	1.04%
Return on Capital (ROIC)	-0.61%	-5.69%	2.02%	5.55%	0.92%	1.26%
Earnings Yield	-4.07%	-5.66%	0.22%	0.66%	1.02%	0.86%
FCF Yield	1.87%	-4.78%	5.52%	4.45%	3.16%	1.90%
Buyback Yield / Dilution	-7.43%	0.09%	-0.71%	-3.16%	-2.59%	-1.65%
Total Shareholder Return	-7.43%	0.09%	-0.71%	-3.16%	-2.59%	-1.65%

Source: S&P Capital IQ. Standard template. Financial Sources.